Cronos Group Inc. (CRON) stock
CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3010% below fair value
$3.17−0.02 (-0.63%)
Close on Nov 18, 2026Market cap $1.17BP/E 15.8Yield –
Cronos free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Cronos's free cash flow for the twelve months ending Jun 30, 2026 was $49.82M. For fiscal 2025 it was $149.00K, down 97.7% from the year before. The highest annual figure on record is $6.43M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $149.00K | -97.7% |
| FY2024 | Dec 31, 2024 | $6.43M | – |
| FY2023 | Dec 31, 2023 | -$45.34M | – |
| FY2022 | Dec 31, 2022 | -$92.40M | – |
| FY2021 | Dec 31, 2021 | -$164.76M | – |
| FY2020 | Dec 31, 2020 | -$176.28M | – |
| FY2019 | Dec 31, 2019 | -$169.86M | – |
| FY2018 | Dec 31, 2018 | -$95.83M | – |
| FY2017 | Dec 31, 2017 | -$37.20M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.27M | – |
| Q1 FY2026 | Mar 31, 2026 | $9.02M | – |
| Q4 FY2025 | Dec 31, 2025 | $9.70M | +132.1% |
| Q3 FY2025 | Sep 30, 2025 | $8.83M | +70.8% |
| Q2 FY2025 | Jun 30, 2025 | -$1.02M | -200.4% |
| Q1 FY2025 | Mar 31, 2025 | -$17.35M | – |
| Q4 FY2024 | Dec 31, 2024 | $4.18M | -73.2% |
| Q3 FY2024 | Sep 30, 2024 | $5.17M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.02M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.93M | – |
| Q4 FY2023 | Dec 31, 2023 | $15.60M | – |
| Q3 FY2023 | Sep 30, 2023 | -$172.00K | – |
| Q2 FY2023 | Jun 30, 2023 | -$12.27M | – |
| Q1 FY2023 | Mar 31, 2023 | -$48.50M | – |
| Q4 FY2022 | Dec 31, 2022 | -$24.74M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.25M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.79M | – |
| Q1 FY2022 | Mar 31, 2022 | -$34.62M | – |
| Q4 FY2021 | Dec 31, 2021 | -$36.43M | – |
| Q3 FY2021 | Sep 30, 2021 | -$33.79M | – |
| Q2 FY2021 | Jun 30, 2021 | -$41.25M | – |
| Q1 FY2021 | Mar 31, 2021 | -$53.30M | – |
| Q4 FY2020 | Dec 31, 2020 | -$48.41M | – |
| Q3 FY2020 | Sep 30, 2020 | -$36.16M | – |
| Q2 FY2020 | Jun 30, 2020 | -$46.41M | – |
| Q1 FY2020 | Mar 31, 2020 | -$45.31M | – |
| Q4 FY2019 | Dec 31, 2019 | -$55.44M | – |
| Q3 FY2019 | Sep 30, 2019 | -$36.73M | – |
| Q2 FY2019 | Jun 30, 2019 | -$53.73M | – |
| Q1 FY2019 | Mar 31, 2019 | -$23.96M | – |
See a number that looks wrong?